Viz.ai is a leader in applied artificial intelligence in healthcare. We are on a mission to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care.
Viz.ai’s flagship product leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. We leverage the speed and accuracy of our algorithms to help connect the right patient to the right doctor at the right time, making sure patients get the life-saving treatment they need, when they need it. Viz.ai obtained a historic FDA clearance for our stroke technology and is the first AI software to receive a CMS New Technology Add-on Payment, Viz.ai has been honored with numerous awards, including being among Fast Company’s Most Innovative Companies and recognition by UCSF as the best new application of AI in digital health. Viz.ai is currently used in more than 700 hospitals.
Viz.ai is funded by top-tier Silicon Valley investors, including Green Oaks, Kleiner Perkins, Google Ventures, Threshold, CRV, Scale Venture Partners and Insight Partners. We are currently located in San Francisco and Tel Aviv, and are expanding into Europe and the broader EMEA region.